搜尋結果
2024年4月24日 · Credit: BioNTech. Germany-based biotechnology company BioNTech opened its first modular messenger ribonucleic acid (mRNA) vaccine manufacturing facility in Kigali, Rwanda, to promote sustainable vaccine production and end-to-end vaccine supply in African Union member states. The facility will manufacture mRNA vaccines as part of the company’s ...
2024年4月19日 · COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020. According to the CDC, the updated mRNA COVID vaccines for 2023-2024 are manufactured using a similar process to the previous vaccines.
2022年9月15日 · According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial. Its rival Moderna said earlier this month, however, that it has ...
2024年5月6日 · First-quarter revenues plunged to 187.6 million euros from last year's 1.28 billion euros. Looking ahead, for fiscal 2024, BioNTech continues to expect total revenues in the range of 2.5 billion ...
6 天前 · Investors in BioNTech SE ( NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88 following the release of its quarterly results. Revenue was dismal, with revenues of €188m ...
2024年5月7日 · Get Biontech SE (22UAy.DE) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Exclusive news, data and analytics for financial market ...
2024年5月6日 · Business category BioNTech says 90% of 2024 revenues will accrue at end of year May 6, 2024 Business category Moderna expects CDC to view its RSV vaccine as equal to rival shots May 2, 2024
